Travere Therapeutics, Inc. (TVTX)
42.90
+0.33
(+0.78%)
USD |
NASDAQ |
May 18, 16:00
42.90
0.00 (0.00%)
After-Hours: 17:20
Travere Therapeutics Market Cap : 3.989B for May 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Revolution Medicines, Inc. | 30.67B |
| AbbVie, Inc. | 370.05B |
| Mirum Pharmaceuticals, Inc. | 5.825B |
| Anika Therapeutics, Inc. | 198.79M |
| BioCryst Pharmaceuticals, Inc. | 2.282B |
Market Cap Related Metrics
| PS Ratio | 7.475 |
| Price to Book Value | 40.41 |
| Price | 42.90 |
| Earnings Yield | -1.25% |